Literature DB >> 19631504

Hybrid repair of bilateral subclavian artery aneurysms in a patient with Marfan syndrome.

Jonathan N Bowman1, Sharif H Ellozy, Konstadinos Plestis, Michael L Marin, Peter L Faries.   

Abstract

A 32-year-old man with Marfan syndrome presented with enlarging, asymptomatic bilateral subclavian artery aneurysms. He has an extensive surgical history including aortic arch and descending thoracic aorta replacement. The L aneurysm was treated first with an L carotid-vertebral artery vein bypass, aneurysm debranching, and stent-graft repair of aneurysm via the L brachial artery approach. The R aneurysm was treated by placing a stent graft from the proximal R common carotid artery across the R subclavian artery origin and landing in the prosthetic innominate bypass graft via an L common carotid artery conduit. An aneurysm debranching and R carotid-subclavian artery bypass completed the procedure. A proximal type I endoleak was detected in the R aneurysm sac on follow-up computed tomography angiography. This was treated with sternotomy, aorta to L common carotid artery bypass, stent graft removal, and oversewing of the R subclavian artery origin. The patient recovered uneventfully. Subclavian artery aneurysms are rarely diagnosed in patients with Marfan disease. Although durability remains unproven, hybrid repair should be considered in patients with subclavian artery aneurysms, to minimize the morbidity commonly associated with open repair. Copyright 2010 Annals of Vascular Surgery Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19631504     DOI: 10.1016/j.avsg.2009.04.005

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  1 in total

1.  Combination of familial Barlow's disease with bilateral axillary artery aneurysms in two brothers.

Authors:  Hirofumi Kasahara; Mikihiko Kudo; Ryohei Yozu; Susumu Hosoda; Akira Shiikawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-02-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.